← Back to Analyst Consensus 
PAHC Hold
PHIBRO ANIMAL HEALTH CORP
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 14, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 15, 2026 | Citigroup | initiate | — → Neutral | — | 54% |
| Nov 7, 2025 | JP Morgan | maintain | Overweight → Overweight | $50 | 55% |
| Aug 29, 2025 | B of A Securities | maintain | Underperform → Underperform | $27 | 53% |
| Jul 7, 2025 | JP Morgan | upgrade | Neutral → Overweight | $35 | 55% |
| Jun 25, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $26 | 54% |
| May 8, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $21 | 54% |
| Feb 10, 2025 | Barclays | maintain | Underweight → Underweight | $22 | 53% |
| Dec 17, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $25 | 54% |
| Nov 12, 2024 | Barclays | maintain | Underweight → Underweight | $20 | 53% |
| Sep 10, 2024 | JP Morgan | initiate | — → Neutral | $22 | 55% |
| Aug 30, 2024 | B of A Securities | maintain | Underperform → Underperform | $15 | 53% |
| May 10, 2024 | Barclays | maintain | Underweight → Underweight | $13 | 53% |
| Nov 9, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $16 | 54% |
| Sep 1, 2023 | Roth MKM | reiterate | Buy → Buy | $21 | 52% |
| Aug 31, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| Aug 29, 2023 | Roth MKM | reiterate | Buy → Buy | $21 | 52% |
| Jul 27, 2023 | Morgan Stanley | reiterate | Equal-Weight → Equal-Weight | $18 | 54% |
| May 4, 2023 | Morgan Stanley | maintain | — → Equal-Weight | $18 | 54% |
| Feb 9, 2023 | Morgan Stanley | maintain | — → Equal-Weight | $19 | 54% |
| Dec 21, 2022 | Roth Capital | initiate | — → Buy | $18 | 53% |
| Nov 10, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $20 | 54% |
| Sep 16, 2022 | Barclays | maintain | — → Underweight | $17 | 53% |
| Aug 26, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $21 | 54% |
| Jul 25, 2022 | Barclays | downgrade | Equal-Weight → Underweight | $22 | 53% |
| Jan 10, 2022 | Barclays | upgrade | Underweight → Equal-Weight | $23 | 53% |
| Nov 18, 2021 | Morgan Stanley | initiate | — → Equal-Weight | $23 | 54% |
| Jul 7, 2021 | Barclays | downgrade | Equal-Weight → Underweight | $23 | 53% |
| May 13, 2021 | Morgan Stanley | maintain | — → Underweight | $22 | 54% |
| May 8, 2020 | Credit Suisse | maintain | — → Neutral | $23 | — |
| Feb 6, 2020 | Gabelli & Co. | downgrade | Buy → Hold | $0 | — |
| Jan 28, 2020 | Barclays | upgrade | Underweight → Equal-Weight | $23 | 53% |
| Sep 5, 2019 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $21 | 54% |
| Aug 29, 2019 | B of A Securities | reiterate | — → Underperform | $18 | 53% |
| Aug 29, 2019 | Barclays | maintain | — → Underweight | $18 | 53% |
| Aug 28, 2019 | Credit Suisse | reiterate | — → Neutral | $25 | — |
| Jun 11, 2019 | Barclays | initiate | — → Underweight | $25 | 53% |
| May 9, 2019 | Gabelli & Co. | upgrade | Hold → Buy | $0 | — |
| Aug 29, 2018 | Morgan Stanley | maintain | Underweight → Underweight | $46 | 54% |
| Jul 5, 2018 | Barclays | maintain | Underweight → Underweight | $33 | 53% |
| May 9, 2018 | Credit Suisse | maintain | Neutral → Neutral | $42 | — |
| Feb 7, 2018 | Morgan Stanley | maintain | Underweight → Underweight | $36 | 54% |
| Feb 6, 2018 | Credit Suisse | maintain | Neutral → Neutral | $39 | — |
| Aug 31, 2017 | Credit Suisse | maintain | — → Outperform | $37 | — |
| Dec 15, 2016 | Piper Sandler | initiate | — → Overweight | $32 | 54% |
| Nov 11, 2016 | Macquarie | downgrade | Neutral → Underperform | $0 | 56% |
| Nov 10, 2016 | Gabelli & Co. | downgrade | Buy → Hold | $0 | — |
| Feb 17, 2016 | Macquarie | maintain | — → Neutral | $35 | 56% |
| Feb 3, 2016 | Credit Suisse | initiate | — → Outperform | $42 | — |
| Jan 15, 2016 | Barclays | downgrade | Overweight → Underweight | $31 | 53% |
Price Target Trend
Apr 25, 2026 Latest: $47 Oct 25, 2026
EPS Estimates
0q $0.78
Lo: $0.76 Hi: $0.81
3 analysts +1q $0.94
Lo: $0.91 Hi: $0.97
2 analysts ▲1
0y $3.50
Lo: $3.48 Hi: $3.51
3 analysts ▲5
+1y $3.85
Lo: $3.68 Hi: $4.10
3 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days